clinical complexity slows uptake Long-acting or micro-dosages (e.g., monthly injections, microneedle patches) What changes: Improved tolerability, better adherence Where it moves : Possibly back toward DTC models if access outpaces infra Strategic shift: Less patient burden, potential wedge for intermediaries Risk: Manufacturing lag or cost may stall rollout
Hersa womens telehealth company that launched in 2018 with a focus on sexual wellness and skincare and has since become better known for offering weight loss drugswarned me that my prescription would not be evaluated for safety, effectiveness, or quality by the FDA. It asked me harrowing questions such as, How disruptive would vomiting, constipation, and diarrhea be to your daily life? And then, thank God, Hers told me I didnt qualify
Intake of antioxidant nutrients and risk of non-Hodgkin's Lymphoma in the Women's Health Initiative
The duration of treatment depends on your individual goals and how your body responds